Spinal Recurrence From Intracranial Germinoma: Risk Factors and Treatment Outcome for Spinal Recurrence

Kazuhiko Ogawa, Yoshihiko Yoshii, Naoto Shikama, Katsumasa Nakamura, Takashi Uno, Hiroshi Onishi, Jun Itami, Yoshiyuki Shioyama, Shiro Iraha, Akio Hyodo, Takafumi Toita, Yasumasa Kakinohana, Wakana Tamaki, Hisao Ito, Sadayuki Murayama

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose: To analyze retrospectively the risk factors of spinal recurrence in patients with intracranial germinoma and clinical outcomes of patients who developed spinal recurrence. Methods and Materials: Between 1980 and 2007, 165 patients with no evidence of spinal metastases at diagnosis were treated with cranial radiotherapy without spinal irradiation. The median follow-up in all 165 patients was 61.2 months (range, 1.2-260.1 months). Results: After the initial treatment, 15 patients (9.1%) developed spinal recurrences. Multivariate analysis revealed that large intracranial disease (≥4 cm) and multifocal intracranial disease were independent risk factors for spinal recurrence. Radiation field, total radiation dose, and the use of chemotherapy did not affect the occurrence of spinal recurrences. Of the 15 patients who experienced spinal recurrence, the 3-year actuarial overall survival and disease-free survival (DFS) rates from the beginning of salvage treatments were 65% and 57%, respectively. In the analysis, presence of intracranial recurrence and salvage treatment modality (radiotherapy with chemotherapy vs. radiotherapy alone) had a statistically significant impact on DFS. The 3-year DFS rate in patients with no intracranial recurrence and treated with both spinal radiotherapy and chemotherapy was 100%, whereas only 17% in patients with intracranial recurrence or treated with radiotherapy alone (p = 0.001). Conclusion: Large intracranial disease and multifocal intracranial disease were risk factors for spinal recurrence in patients with intracranial germinoma with no evidence of spinal metastases at diagnosis. For patients who developed spinal recurrence alone, salvage treatment combined with spinal radiotherapy and chemotherapy was effective in controlling the recurrent disease.

Original languageEnglish
Pages (from-to)1347-1354
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume72
Issue number5
DOIs
Publication statusPublished - Dec 1 2008

Fingerprint

Germinoma
Recurrence
radiation therapy
Radiotherapy
chemotherapy
Salvage Therapy
Disease-Free Survival
Drug Therapy
metastasis
Survival Rate
Radiation
Neoplasm Metastasis
radiation distribution
Multivariate Analysis
occurrences

All Science Journal Classification (ASJC) codes

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Spinal Recurrence From Intracranial Germinoma : Risk Factors and Treatment Outcome for Spinal Recurrence. / Ogawa, Kazuhiko; Yoshii, Yoshihiko; Shikama, Naoto; Nakamura, Katsumasa; Uno, Takashi; Onishi, Hiroshi; Itami, Jun; Shioyama, Yoshiyuki; Iraha, Shiro; Hyodo, Akio; Toita, Takafumi; Kakinohana, Yasumasa; Tamaki, Wakana; Ito, Hisao; Murayama, Sadayuki.

In: International Journal of Radiation Oncology Biology Physics, Vol. 72, No. 5, 01.12.2008, p. 1347-1354.

Research output: Contribution to journalArticle

Ogawa, K, Yoshii, Y, Shikama, N, Nakamura, K, Uno, T, Onishi, H, Itami, J, Shioyama, Y, Iraha, S, Hyodo, A, Toita, T, Kakinohana, Y, Tamaki, W, Ito, H & Murayama, S 2008, 'Spinal Recurrence From Intracranial Germinoma: Risk Factors and Treatment Outcome for Spinal Recurrence', International Journal of Radiation Oncology Biology Physics, vol. 72, no. 5, pp. 1347-1354. https://doi.org/10.1016/j.ijrobp.2008.03.055
Ogawa, Kazuhiko ; Yoshii, Yoshihiko ; Shikama, Naoto ; Nakamura, Katsumasa ; Uno, Takashi ; Onishi, Hiroshi ; Itami, Jun ; Shioyama, Yoshiyuki ; Iraha, Shiro ; Hyodo, Akio ; Toita, Takafumi ; Kakinohana, Yasumasa ; Tamaki, Wakana ; Ito, Hisao ; Murayama, Sadayuki. / Spinal Recurrence From Intracranial Germinoma : Risk Factors and Treatment Outcome for Spinal Recurrence. In: International Journal of Radiation Oncology Biology Physics. 2008 ; Vol. 72, No. 5. pp. 1347-1354.
@article{4ad3ac8017be49289bc33417d4d6fe91,
title = "Spinal Recurrence From Intracranial Germinoma: Risk Factors and Treatment Outcome for Spinal Recurrence",
abstract = "Purpose: To analyze retrospectively the risk factors of spinal recurrence in patients with intracranial germinoma and clinical outcomes of patients who developed spinal recurrence. Methods and Materials: Between 1980 and 2007, 165 patients with no evidence of spinal metastases at diagnosis were treated with cranial radiotherapy without spinal irradiation. The median follow-up in all 165 patients was 61.2 months (range, 1.2-260.1 months). Results: After the initial treatment, 15 patients (9.1{\%}) developed spinal recurrences. Multivariate analysis revealed that large intracranial disease (≥4 cm) and multifocal intracranial disease were independent risk factors for spinal recurrence. Radiation field, total radiation dose, and the use of chemotherapy did not affect the occurrence of spinal recurrences. Of the 15 patients who experienced spinal recurrence, the 3-year actuarial overall survival and disease-free survival (DFS) rates from the beginning of salvage treatments were 65{\%} and 57{\%}, respectively. In the analysis, presence of intracranial recurrence and salvage treatment modality (radiotherapy with chemotherapy vs. radiotherapy alone) had a statistically significant impact on DFS. The 3-year DFS rate in patients with no intracranial recurrence and treated with both spinal radiotherapy and chemotherapy was 100{\%}, whereas only 17{\%} in patients with intracranial recurrence or treated with radiotherapy alone (p = 0.001). Conclusion: Large intracranial disease and multifocal intracranial disease were risk factors for spinal recurrence in patients with intracranial germinoma with no evidence of spinal metastases at diagnosis. For patients who developed spinal recurrence alone, salvage treatment combined with spinal radiotherapy and chemotherapy was effective in controlling the recurrent disease.",
author = "Kazuhiko Ogawa and Yoshihiko Yoshii and Naoto Shikama and Katsumasa Nakamura and Takashi Uno and Hiroshi Onishi and Jun Itami and Yoshiyuki Shioyama and Shiro Iraha and Akio Hyodo and Takafumi Toita and Yasumasa Kakinohana and Wakana Tamaki and Hisao Ito and Sadayuki Murayama",
year = "2008",
month = "12",
day = "1",
doi = "10.1016/j.ijrobp.2008.03.055",
language = "English",
volume = "72",
pages = "1347--1354",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Spinal Recurrence From Intracranial Germinoma

T2 - Risk Factors and Treatment Outcome for Spinal Recurrence

AU - Ogawa, Kazuhiko

AU - Yoshii, Yoshihiko

AU - Shikama, Naoto

AU - Nakamura, Katsumasa

AU - Uno, Takashi

AU - Onishi, Hiroshi

AU - Itami, Jun

AU - Shioyama, Yoshiyuki

AU - Iraha, Shiro

AU - Hyodo, Akio

AU - Toita, Takafumi

AU - Kakinohana, Yasumasa

AU - Tamaki, Wakana

AU - Ito, Hisao

AU - Murayama, Sadayuki

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Purpose: To analyze retrospectively the risk factors of spinal recurrence in patients with intracranial germinoma and clinical outcomes of patients who developed spinal recurrence. Methods and Materials: Between 1980 and 2007, 165 patients with no evidence of spinal metastases at diagnosis were treated with cranial radiotherapy without spinal irradiation. The median follow-up in all 165 patients was 61.2 months (range, 1.2-260.1 months). Results: After the initial treatment, 15 patients (9.1%) developed spinal recurrences. Multivariate analysis revealed that large intracranial disease (≥4 cm) and multifocal intracranial disease were independent risk factors for spinal recurrence. Radiation field, total radiation dose, and the use of chemotherapy did not affect the occurrence of spinal recurrences. Of the 15 patients who experienced spinal recurrence, the 3-year actuarial overall survival and disease-free survival (DFS) rates from the beginning of salvage treatments were 65% and 57%, respectively. In the analysis, presence of intracranial recurrence and salvage treatment modality (radiotherapy with chemotherapy vs. radiotherapy alone) had a statistically significant impact on DFS. The 3-year DFS rate in patients with no intracranial recurrence and treated with both spinal radiotherapy and chemotherapy was 100%, whereas only 17% in patients with intracranial recurrence or treated with radiotherapy alone (p = 0.001). Conclusion: Large intracranial disease and multifocal intracranial disease were risk factors for spinal recurrence in patients with intracranial germinoma with no evidence of spinal metastases at diagnosis. For patients who developed spinal recurrence alone, salvage treatment combined with spinal radiotherapy and chemotherapy was effective in controlling the recurrent disease.

AB - Purpose: To analyze retrospectively the risk factors of spinal recurrence in patients with intracranial germinoma and clinical outcomes of patients who developed spinal recurrence. Methods and Materials: Between 1980 and 2007, 165 patients with no evidence of spinal metastases at diagnosis were treated with cranial radiotherapy without spinal irradiation. The median follow-up in all 165 patients was 61.2 months (range, 1.2-260.1 months). Results: After the initial treatment, 15 patients (9.1%) developed spinal recurrences. Multivariate analysis revealed that large intracranial disease (≥4 cm) and multifocal intracranial disease were independent risk factors for spinal recurrence. Radiation field, total radiation dose, and the use of chemotherapy did not affect the occurrence of spinal recurrences. Of the 15 patients who experienced spinal recurrence, the 3-year actuarial overall survival and disease-free survival (DFS) rates from the beginning of salvage treatments were 65% and 57%, respectively. In the analysis, presence of intracranial recurrence and salvage treatment modality (radiotherapy with chemotherapy vs. radiotherapy alone) had a statistically significant impact on DFS. The 3-year DFS rate in patients with no intracranial recurrence and treated with both spinal radiotherapy and chemotherapy was 100%, whereas only 17% in patients with intracranial recurrence or treated with radiotherapy alone (p = 0.001). Conclusion: Large intracranial disease and multifocal intracranial disease were risk factors for spinal recurrence in patients with intracranial germinoma with no evidence of spinal metastases at diagnosis. For patients who developed spinal recurrence alone, salvage treatment combined with spinal radiotherapy and chemotherapy was effective in controlling the recurrent disease.

UR - http://www.scopus.com/inward/record.url?scp=56349170738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56349170738&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2008.03.055

DO - 10.1016/j.ijrobp.2008.03.055

M3 - Article

C2 - 18513888

AN - SCOPUS:56349170738

VL - 72

SP - 1347

EP - 1354

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -